<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5090662 Figure_1-A</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Serum IgG ELISA reactivity with MTB (H37Rv) whole cell lysate, purified cell membrane fraction and secreted culture filtrate proteins (CFP) for TB patients and healthy donors (HD). ELISA graphs (left; TB: black lines; n=25; HD: red dotted lines; n=2) and area under the curve (AUC) values for all tested samples (right; TB: n=25; HD: n=17) are shown. Median is shown.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_1-B</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) AUC values for the IgA serum ELISA response against MTB whole cell lysate, purified cell membrane fraction and secreted culture filtrate proteins (CFP) of TB patients (n=25) and healthy donors (HD; n=9). Median is shown.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_1-C</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Flow cytometry gating strategy and frequency of circulating plasmablasts (CD19+CD27++CD38+) for one representative TB patient (TB24) and HD (left). Frequency of circulating CD19+CD27++CD38+plasmablasts of all CD19+ B cells in peripheral blood of TB patients (n=24) and HD (n=8). Dashed line indicates threshold for detectable plasmablast populations (right). Median and SEM are shown.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_1-D</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Expression of CD19 and activation markers (CD86, CD84 and CD24) in plasmablasts and memory B cells as measured by flow cytometry.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_1-E</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Plasmablast response of patient TB7 (top) and IgG serum response against MTB cell lysate of patient TB7, TB19 and TB39 (bottom) and one HD at the indicated time points before and after treatment onset.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_1-F</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Dots indicate AUC values for the anti-MTB cell lysate IgG serum ELISA response (y-axis) versus frequency of circulating plasmablasts (x-axis) for individual TB patients.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-A</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Gating strategy, phenotype and frequency of circulating plasmablasts (CD19+CD27++CD38+) isolated by flow cytometric cell sorting from 3 TB patients (TB7, TB24, TB33) in comparison to one representative HD. Boxes indicate sort gates. The plasmablast frequency is indicated.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-B</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Absolute number of somatic hypermutations (SHM) in the IGHV, IGKV and IGLV segments of IgA and IgG plasmablast antibody genes sequenced from TB7, TB24 and TB33. The absolute number of sequences analyzed is indicated below the graph. Geometric means with SEM are indicated in grey. SHM means of historic data from sorted CD27+IgA+ or CD27+IgG+ cells from peripheral blood of HD are indicated in red for comparison (Berkowska et al, 2015a; Tiller et al, 2007).</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-C</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Isotype distribution of plasmablast and memory B cells from TB7, TB24 and TB33. PB, plasmablasts (CD19+CD27++CD38+); M, memory B cells (CD19+CD27+).</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-D</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Gating strategy, phenotype and frequency of HBHA-reactive memory B cells (CD19+CD27+HBHA+) in peripheral blood of one representative TB patient (TB29), health-care worker (HCW) 2 and HD, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-E</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Dots indicate frequency of HBHA-reactive memory B cells out of all CD27+ memory B cells in individual TB patients (n=23) and HCWs (n=7). Mean and SEM are indicated. P-value was determined using Wilcoxon-Mann-Whitney test; ****p&lt;0.0001.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-F</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Dots indicate the frequency of resting memory B cells (CD19+CD27+CD10-) out of all B cells in peripheral blood of individual TB patients compared to HD.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-G</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Anti-HBHA serum IgG ELISA reactivity for TB patients and HCW (black lines) compared to two representative HD (red lines). Dashed line indicates the threshold OD405nm for positive reactivity (left). Asterisks indicate serum responses of donors selected for single sorting of HBHA-reactive memory B cells. Data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-H</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Absolute number of somatic hypermutations (SHM) in the IGHV (IGHA, IGHG and IGHM), IGKV or IGLV segments of sorted anti-HBHAmemory cells from TB patients and HCWs. Geometric means with SEM are indicated in grey. For comparison, red lines indicate the historic SHM means for randomly sorted CD27+IgA+, CD27+IgG+ or CD27+IgM+ cells from peripheral blood of HDs (Berkowska et al, 2015a; Tiller et al, 2007; Tsuiji et al, 2006).</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-I</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-I</infon>
    <infon key="sourcedata_figure_dir">Figure_2-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) Number and size of clonally expanded B cell clusters among HBHA-reactive memory B cells from two TB patients (TB35, TB29) and HCWs (HCW1, HCW 2). Cells in clusters are indicated in grey, single cells are indicated in white. No B cell clusters were shared between donors.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_2-J</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 2-J</infon>
    <infon key="sourcedata_figure_dir">Figure_2-J</infon>
    <passage>
      <offset>0</offset>
      <text>(J) IgA, IgG and IgM isotype distribution of single-cell-sorted HBHA-reactive memory cells. Mean and SEM are indicated.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_3-A-B</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A, B) Representative ELISA graphs show reactivity of antibodies from patient TB7 to (A) MTB whole cell lysate or (B) MTB bacteria (left). Dashed red line indicates the threshold OD405nm for positive reactivity. Green line indicates negative control antibody (mGO53; (Wardemann et al, 2003)). AUC (area under curve) values indicate the reactivity to (A) MTB cell lysate or (B) whole MTB bacteria for antibodies from TB7, TB24, TB33. Total numbers of analyzed antibodies are indicated (right).</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_3-D</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) ELISA graph shows reactivity to the MTB cell membrane fraction for MTB-reactive (n=26) and non-reactive (n=14) antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_3-E</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Reactivity to whole BCG bacteria as determined by flow cytometry for three representative MTB cell lysate-reactive antibodies and one non-reactive antibody (isotype control, mGO53).</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_4-A</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Binding of antibodies TB24PB037 and TB33PB123 to LAM purified from MTB as determined by Western Blot. The negative isotype control (mGO53) and a commercially available anti-LAM antibody (positive control) are shown for comparison.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_4-B</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Anti-BCG specificity of the LAM-reactive antibody TB24PB037 (black) compared to E.coli as determined by ELISA with whole bacteria (left) and flow cytometry (right).</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_4-C</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Anti-LAM ELISA for TB24PB037 or negative control antibody at the indicated concentrations. The mean &#177;SD of the absorbance was calculated.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_4-D</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Antibody TB24PB037 binds to MTB-LAM but not to LAM from M. smegmatis. ELISA performed as described in (C).</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_4-E</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Representative HBHA ELISA for antibodies cloned from HBHA-reactive memory B cells of patient TB35 and HCW1. Dashed red line indicates the threshold OD405nm for positive reactivity. Green line indicates negative control antibody (mGO53; (Wardemann et al, 2003)).</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_4-F</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Reactivity to HBHA was confirmed by Western Blot for a selected set of antibodies with HBHA ELISA reactivity.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_4-G</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Fluorescence microscopy shows BCG- and MTB-reactivity of representative anti-HBHA antibodies compared to a non-reactive isotype control antibody. Scale bar 10 &#956;m (top/bottom).</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_5-A</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>Relative bacterial counts (CFU) compared to the medium control (100%) in human lung epithelial A549 cells 1 h after infection with MTB, pre-incubated with recombinant MTB-reactive IgA1, IgA2 or IgG1 antibodies and non-reactive isotype control as indicated. (A) Representative results for individual MTB-reactive plasmablast antibodies. Mean and SEM are indicated.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_5-B</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>Relative bacterial counts (CFU) compared to the medium control (100%) in human lung epithelial A549 cells 1 h after infection with MTB, pre-incubated with recombinant MTB-reactive IgA1, IgA2 or IgG1 antibodies and non-reactive isotype control as indicated. (B) Direct comparison of all tested MTB-reactive IgA (n=12) and IgG (n=26) antibodies. Mean and SEM are indicated.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_5-C</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>Relative bacterial counts (CFU) compared to the medium control (100%) in human lung epithelial A549 cells 1 h after infection with MTB, pre-incubated with recombinant MTB-reactive IgA1, IgA2 or IgG1 antibodies and non-reactive isotype control as indicated. (C) Representative results for individual HBHA-reactive memory B cell antibodies from TB patients and HCW.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_5-D</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>Relative bacterial counts (CFU) compared to the medium control (100%) in human lung epithelial A549 cells 1 h after infection with MTB, pre-incubated with recombinant MTB-reactive IgA1, IgA2 or IgG1 antibodies and non-reactive isotype control as indicated. (D) Same as in (B) but with HBHA-reactive antibodies as shown in (C). (D) Direct comparison all tested HBHA-reactive IgA (n=6) and IgG (n=7) antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_5-E</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>Relative bacterial counts (CFU) compared to the medium control (100%) in human lung epithelial A549 cells 1 h after infection with MTB, pre-incubated with recombinant MTB-reactive IgA1, IgA2 or IgG1 antibodies and non-reactive isotype control as indicated. (E) Direct comparison of the indicated MTB-reactive antibodies expressed as IgA and IgG. Mean and SEM are indicated. P-values were determined using non-parameric t-test, * p&lt;0.1; **p&lt;0.01, ns: p&gt;0.5.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_6-A</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Human lung epithelial A549 cells and primary bronchial epithelial cells (hAECB) lack Fc&#947;R (CD16, CD64 and CD32) and Fc&#945;R (CD89) cell surface expression as analyzed by flow cytometry. Human THP1 cells serve as positive control.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_6-B</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) The neonatal FcR (FcRn) is expressed in both A549 cells and human THP1 cells as determined by Western Blotting. Data are representative of at least two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_6-C</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Absolute bacterial counts (CFUs) in human THP1 macrophages 1 h after infection with MTB pre-incubated with the LAM-reactive IgA1 (left) or IgG1 (right) antibody TB24PB037 or the respective isotype control antibody as indicated. Mean and SEM are indicated.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_7-A</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Absolute bacterial counts (CFUs) in human lung epithelial A549 cells 1 h after infection with MTB pre-incubated with purified serum IgA (left) or IgG (right) antibodies from TB patients (TB) compared to HD as indicated. Mean and SEM are indicated. Data are representative of three independent experiments with three technical replicates each.</text>
    </passage>
  </document>
  <document>
    <id>5090662 Figure_7-B</id>
    <infon key="sourcedata_document">2313</infon>
    <infon key="doi">10.15252/emmm.201606330</infon>
    <infon key="pmc_id">5090662</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Direct comparison of purified serum IgA and IgG antibodies on epithelial cell invasion as measured in (A). P-value was determined using Wilcoxon-Mann-Whitney test; ****p&lt;0.0001.</text>
    </passage>
  </document>
</collection>
